Early prediction of severe ICANS after standard-of-care CD19 CAR T-cell therapy using gradient-boosted classification trees.
Jennifer J. Huang(Stanford Medicine), Jordan Gauthier(Seattle Cancer Care Alliance), David G. Maloney(Fred Hutch Cancer Center), Natalie Wuliji(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Aiko Torkelson(Fred Hutch Cancer Center), Andrew J. Portuguese(University of Washington), Aude G. Chapuis(University of Washington), Brian G. Till(University of Washington), Alexandre V. Hirayama(University of Washington), Mazyar Shadman(University of Washington), Delaney Kirchmeier(Fred Hutch Cancer Center), Filippo Milano(Fred Hutch Cancer Center), Lorenzo Iovino(University of Pisa), Folashade Otegbeye(University Hospitals of Cleveland), Aya Albittar(University of Washington), Ryan D. Cassaday(University of Washington), Emily C. Liang(Fred Hutch Cancer Center), Abigail Chutnik(Fred Hutch Cancer Center), Barbara Pender(Fred Hutch Cancer Center), Erik L. Kimble(University of Washington)
Cited by 2